Claire Poll, General Counsel at Verona Pharma plc (VRNA), sold 159,056 shares at $2.50 ($174K) on 2023-08-04, disclosed to the SEC on 2023-08-07.
Scheduled sale ($174k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.54 | 20,608 | $52K | 30.0% |
| 2 | $2.54 | 20,608 | $52K | 30.0% |
| 3 | $2.50 | 26,352 | $66K | 37.8% |
| 4 | $0.00 | 89,976 | $0 | 0.0% |
| 5 | $2.47 | 1,512 | $4K | 2.1% |
| Total | $1.10 avg | 159,056 |
| $174K |
| 100% |
| Filing → |
| VRNA | SELL | 2023-02-03 | $394K | — | Filing → |
| VRNA | SELL | 2022-12-27 | $646K | — | Filing → |